TrialAdvances in rheumatology (London, England)2023

Safety and immunogenicity of influenza A(H3N2) component vaccine in juvenile systemic lupus erythematosus.

Nadia Emi Aikawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.